Rite Aid Falls Despite A Strong Q2'15 As It Lowers Its 2015 Guidance

The company's stock price has declined by 18.5% because management lowered its fiscal 2015 guidance (mentioned at the end of the article), mainly due to an anticipated decline in reimbursement rates and lower profitability from generic drugs in the second half of the fiscal.